Insider · CIK 0001825163
Danilo D'Alessandro
cfoofficer
Files at CLPT (ClearPoint Neuro, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | CLPT ClearPoint Neuro, Inc. | FTax withholding Common Stock | -4,754 | $13.29 | $63k | 65,992 | Jun 12, 2025 |
| Mar 12, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Common Stock | +16,313 | - | - | 79,030 | Mar 14, 2025 |
| Mar 12, 2025 | CLPT ClearPoint Neuro, Inc. | FTax withholding Common Stock | -8,284 | $13.18 | $109k | 70,746 | Mar 14, 2025 |
| Mar 12, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,313 | - | - | 65,253 | Mar 14, 2025 |
| Mar 11, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Common Stock | +4,146 | - | - | 64,823 | Mar 13, 2025 |
| Mar 11, 2025 | CLPT ClearPoint Neuro, Inc. | FTax withholding Common Stock | -2,106 | $12.70 | $27k | 62,717 | Mar 13, 2025 |
| Mar 11, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,146 | - | - | 4,145 | Mar 13, 2025 |
| Mar 6, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Common Stock | +18,765 | - | - | 70,206 | Mar 10, 2025 |
| Mar 6, 2025 | CLPT ClearPoint Neuro, Inc. | FTax withholding Common Stock | -9,529 | $13.19 | $126k | 60,677 | Mar 10, 2025 |
| Mar 6, 2025 | CLPT ClearPoint Neuro, Inc. | MOption exercise Restricted Stock Unitsderivative | -18,765 | - | - | 18,765 | Mar 10, 2025 |
| Mar 3, 2025 | CLPT ClearPoint Neuro, Inc. | AGrant or award Restricted Stock Unitsderivative | +51,660 | $0.00 | $0 | 51,660 | Mar 4, 2025 |
| Dec 31, 2024 | CLPT ClearPoint Neuro, Inc. | AGrant or award Common Stock | +1,949 | $4.53 | $8,829 | 51,441 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.